Patents
Sitemap › C07 - Organic chemistry › C07D - Heterocyclic compounds › C07D 401 - Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
Patents for C07D 401 - Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom (107,979)
11/2010
11/10/2010CN101171249B Method for producing indole derivative having piperidine ring
11/10/2010CA2759843A1 Gpr 119 modulators
11/09/2010US7829728 2-[(S)-1-(9-{Benzyl-1,2-(8-benzyloxy-2-oxo-1,2-dihydroquinolin-5-yl)-2-oxoethyl]-amino}nonyl)pyrrolidin-3-yl -2,2-diphenylacetamide; beta 2 adrenergic receptor agonist, muscarinic receptor antagonist activity; chronic obstructive pulmonary disease and asthma
11/09/2010US7829718 Salts of benzimidazole derivative with amines and process for manufacturing the same
11/09/2010US7829713 Therapeutic piperazines
11/09/2010US7829712 Pyridazine derivatives for inhibiting human stearoyl-CoA-desaturase
11/09/2010US7829705 such as 7-{2-[1-(6-methyl-3-pyridazinyl)-4-piperidinyl]ethoxy}-4-ethoxy-cinnoline, used in the treatment of picornavirus infections in humans
11/09/2010US7829586 Aryl-substituted nitrogen-containing heterocyclic compounds
11/09/2010US7829583 Biphenyl derivatives
11/09/2010US7829581 Prodrugs of pyrazoline compounds, their preparation and use as medicaments
11/09/2010US7829580 Cyclic amine derivative having heteroaryl ring
11/09/2010US7829571 monocyte chemotactic protein antagonists such as -(3S)-1-(4-(tert-butylamino)cyclohexyl)-3-(6-(trifluoromethyl)quinazolin-4-ylamino)pyrrolidin-2-one, used for the treatment of asthma, multiple sclerosis, arteriosclerosis and rheumatoid arthritis
11/09/2010US7829568 vanilloid receptor antagonists such as 2-({2-[butyl-(3-chlorobenzoyl)-amino]-5,6,7,8-tetrahydro-imidazo[1,2-a]pyridine-3-carbonyl}-amino)-3-methyl-benzyl butyrate, used as analgesics
11/09/2010US7829563 sleep disorders; (R)-2-[(S)1-(5-chloro-2-methoxy-phenyl)-3-(6-trifluoromethyl-pyridin-3-yl)-propylamino]-2-(4-fluoro-phenyl)-N-methyl-acetamide
11/09/2010CA2602198C Substituted triazole derivatives as oxytocin antagonists
11/09/2010CA2547283C Aminopyrazole derivatives as gsk-3 inhibitors
11/09/2010CA2540845C Aminobenzimidazoles as selective melanin concentrating hormone receptor antagonists for the treatment of obesity and related disorders
11/09/2010CA2520297C Mass labels
11/09/2010CA2496164C Benzimidazole quinolinones and uses thereof
11/09/2010CA2484188C Tachykinin receptor antagonists
11/09/2010CA2453623C 6-aryl-4-aminopicolinates and their use as herbicides
11/09/2010CA2434937C Phenyl derivatives
11/09/2010CA2407659C Growth hormone secretagogues
11/04/2010WO2010127330A1 Dual-action inhibitors and methods of using same
11/04/2010WO2010127329A1 Dual-action inhibitors and methods of using same
11/04/2010WO2010127152A2 Compounds and compositions as microsomal prostaglandin e synthase-1 inhibitors
11/04/2010WO2010126914A1 Pyridinone antagonists of alpha-4 integrins
11/04/2010WO2010126895A1 Inhibitors of pi3 kinase and / or mtor
11/04/2010WO2010126851A1 Cxcr3 receptor antagonists
11/04/2010WO2010126580A1 Insecticidal pyridine compounds
11/04/2010WO2010126178A1 New chlorine e6-folic acid conjugated compound, preparation method thereof, and pharmaceutical composition containing the same for treatment of cancer
11/04/2010WO2010126163A1 Heteroarylthiomethyl pyridine derivative
11/04/2010WO2010126025A1 Quaternary ammonium salt compound
11/04/2010WO2010126002A1 Pharmaceutical product containing heterocyclic sulfonamide compound
11/04/2010WO2010125985A1 Fused heterocyclic compound and use thereof
11/04/2010WO2010125831A1 Sulfamoyl benzoic acid derivatives as trpm8 antagonists
11/04/2010WO2010125811A1 Carbinol compound having heterocyclic linker
11/04/2010WO2010125799A1 Urea derivative having pi3k inhibitory activity
11/04/2010WO2010125402A1 Imidazole derivatives and their use as modulators of cyclin dependent kinases
11/04/2010WO2010125103A1 Diketopiperazine derivatives as p2x7 modulators
11/04/2010WO2010124950A1 New photoinitiators
11/04/2010WO2010124845A1 Pesticidal arylpyrrolidines
11/04/2010WO2010124648A1 Azaazulene compounds
11/04/2010WO2010124619A1 1,2,3-3h pyridine heterocyclic compounds, their agricultural compositions, their use and their preparation methods
11/04/2010WO2010095144A3 Process for preparation of proton pump inhibitors
11/04/2010WO2010076566A3 Indoles useful in the treatment of inflammation
11/04/2010WO2010072781A3 Imine compounds for combating invertebrate pests
11/04/2010WO2009090548A3 3-azabicyclo [3.1.0] hexane derivatives as vanilloid receptor ligands
11/04/2010US20100280251 Process for preparing 2-amino-5-cyanobenzoic acid derivatives
11/04/2010US20100280249 Synthesis of 4-amino-thalidomide enantiomers
11/04/2010US20100280246 Energy transfer dyes with enhanced fluorescence
11/04/2010US20100280077 Process for Preparation of Stable Amorphous R-Lansoprazole
11/04/2010US20100280074 Ccr9 inhibitors and methods of use thereof
11/04/2010US20100280072 2-'4-(hydroxymethyl-phenylamino) -piperidine-1-yl!-n- (9h-carbazol-3yl) - acetamine derivatives and related compounds as neuropeptide y5 (npy5) ligands for the treatment of obesity
11/04/2010US20100280071 Benzimidazoles which have activity at m1 receptor and their uses in medicine
11/04/2010US20100280070 Novel tetrahydroquinolines as aromatase inhibitors
11/04/2010US20100280066 Acylated amino acid amidyl pyrazoles and related compounds
11/04/2010US20100280058 Spirocyclic heterocyclic derivatives and methods of their use
11/04/2010US20100280048 Some 2-pyrazinone derivatives and their use as inhibitors of neutrophile elastase
11/04/2010US20100280042 Quinazoline derivatives for the treatment of tumours
11/04/2010US20100280036 Modulation of Pathogenicity
11/04/2010US20100280034 Modulation of pathogenicity
11/04/2010US20100280033 Pyrazole Derivatives
11/04/2010US20100280030 2-oxo-3-benzylbenzoxazol-2-one derivatives and related compounds as met kinase inhibitors for the treatment of tumours
11/04/2010US20100280028 Cxcr3 receptor antagonists
11/04/2010US20100280024 Renin inhibitors
11/04/2010US20100280020 Isoxazoles
11/04/2010US20100280018 Derivatives Of Hydroxamic Acid As Metalloproteinase Inhibitors
11/04/2010US20100280016 Pyrazoline compounds
11/04/2010US20100280013 Carbinol derivatives having heterocyclic linker
11/04/2010US20100280012 Azaazulene compounds
11/04/2010US20100280011 Dual mechanism inhibitors for the treatment of disease
11/04/2010US20100280010 Chemical compounds
11/04/2010US20100280009 3,4-substituted pyrrolidine beta-secretase inhibitors for the treatment of alzheimer's disease
11/04/2010US20100280008 Aurora kinase modulators and method of use
11/04/2010US20100280007 Pyridazinone Derivatives
11/04/2010US20100280005 Renin Inhibitors
11/04/2010US20100279998 Piperidinylalkylcarbamate derivatives, methods for their preparation and the therapeutic use thereof as fatty acid amido hydrolase enzyme inhibitors
11/04/2010US20100279997 Analgesic that binds filamin a
11/04/2010US20100279991 Tetrahydro-cyclopentyl pyrazole cannabinoid modulators
11/04/2010US20100279340 Imaging agents for protein misfolding
11/04/2010US20100278833 Thiophene-imidazopyridines
11/04/2010US20100278811 Vasculostatic agents and methods of use thereof
11/04/2010US20100278751 Radiolabeled 2-amino-4-alkyl-6-(haloalkyl)pyridine compounds and their use in diagnostic imaging
11/04/2010US20100276673 Organic compound, and organic photoelectric device including the same
11/04/2010US20100276639 Polymer comprising phenyl pyridine units
11/04/2010US20100275389 Method for dyeing keratin fibers using at least one compound of azomethine type comprising a pyrazolopyridine unit
11/04/2010CA2760630A1 Quaternary ammonium salt compounds
11/04/2010CA2760611A1 Dual-action inhibitors and methods of using same
11/04/2010CA2760562A1 Dual mechanism inhibitors for the treatment of disease
11/04/2010CA2760151A1 Pyridinone antagonists of alpha-4 integrins
11/04/2010CA2759859A1 Carbinol compound having heterocyclic linker
11/04/2010CA2759832A1 New photoinitiators
11/04/2010CA2759471A1 Heteroarylthiomethyl pyridine derivative
11/04/2010CA2759385A1 Insecticidal pyridine compounds
11/04/2010CA2759083A1 Imidazole derivatives and their use as modulators of cyclin dependent kinases
11/04/2010CA2758986A1 Inhibitors of pi3 kinase and/or mtor
11/04/2010CA2758961A1 Substituted isoquinoline derivatives, pharmaceutical compositions, and methods of use as .beta.-secretase inhibitors
11/04/2010CA2757761A1 Sulfamoyl benzoic acid derivatives as trpm8 antagonists
11/04/2010CA2747420A1 Azaazulene compounds
1 ... 228 229 230 231 232 233 234 235 236 237 238 239 240 241 242 243 244 245 246 247 248 ... 1080